AzTrials
AzTrials

Autism Spectrum Disorder (ASDNCT07768332

Assessing Outcomes of Three Different Museum-based Social Prescription Programs in Autistic Adults

A study testing Independent museum visit, Guided museum visits and group discussions and Museum visit with a friend in people with Autism Spectrum Disorder (ASD and Autism, run by National Taiwan University Hospital at 1 site in Taiwan.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study will examine whether visiting the National Taiwan Museum can support the social and emotional well-being of autistic adults. The research team plans to recruit 90 autistic adults aged 18 to 50 from the Department of Psychiatry at National Taiwan University Hospital. Read more about this study

Who is it for?
Ages 18 to 50 years
What is being tested?
Independent museum visit, Guided museum visits and group discussions and Museum visit with a friend
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteTaiwan
Study dates
1 May 2024to Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Meet the diagnostic criteria for autism spectrum disorder.
  • Have intellectual functioning within the normal range.
  • Be willing and able to participate in the study procedures.
  • Be willing to attend the relevant museum activities and group discussions, when applicable.
  • Agree to audio and video recording during relevant study activities.

Who cannot join

  • Are unwilling to complete the required assessments.
  • Have a serious physical or psychiatric condition that limits their physical stamina, emotional capacity, or ability to understand and complete the study procedures.
  • Refuse audio or video recording.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Taiwan1 site, 1 recruiting
  • National Taiwan University Hospital

    Taipei

    Yi-Ling Chien, MD, PhD, +886-223123456 ext. 266013, ntuh.peers@gmail.com

    Recruiting

Other trials in Taiwan

About this study

Official title: Exploring the Feasibility of Social Prescription in People on the Autism Spectrum

This study will examine whether visiting the National Taiwan Museum can support the social and emotional well-being of autistic adults.

The research team plans to recruit 90 autistic adults aged 18 to 50 from the Department of Psychiatry at National Taiwan University Hospital. Participants must have average-range intellectual ability and be able and willing to complete the study activities and assessments. People with serious physical or mental health conditions that would prevent full participation will not be included. Participants must also agree to audio and video recording during the activities.

Read more

After an outpatient doctor confirms eligibility, participants will complete questionnaires and choose one of three museum participation options:

  1. Visit the museum once independently.
  2. Join five guided museum visits with group discussions.
  3. Invite a friend to visit the museum together.

Each group will include about 30 participants.

For the guided group, each session will last about 90 minutes and include a professional museum tour, a question-and-answer period, time for independent exploration, and a group discussion. Participants will be encouraged to select exhibits that interest them, record their observations, share their thoughts, listen to others, and respond to different viewpoints.

The five planned museum themes include Taiwan's history and identity, relationships between people and nature, architecture and living spaces, human evolution and the future, and attitudes toward money and financial planning. The discussions will explore everyday topics such as stereotypes, personal values, preferred living environments, hopes for the future, and managing money.

Participants will complete questionnaires before and after the program. These questionnaires will assess areas such as autistic characteristics, social communication, empathy, sensory experiences, comfort with social touch, emotional skills, loneliness, anxiety, depression, and anxiety during social interaction. Participants will also rate how enjoyable, comfortable, safe, interesting, and socially engaging they found the museum activities.

The researchers will compare participants' results before and after the program. They will also compare the three participation options to determine whether independent visits, guided group activities, or visiting with a friend produce different outcomes.

The overall goal is to understand whether museum-based activities can be used as a form of social prescribing to improve social participation, emotional well-being, confidence, and quality of life among autistic adults.

Read the detailed description

This study will evaluate a museum-based social prescribing program for autistic adults with average-range intellectual functioning. Social prescribing is a person-centered approach that connects individuals with nonmedical community resources to support health, well-being, and social participation. Although social prescribing has been applied to people with chronic medical and psychiatric conditions, its effectiveness for autistic adults has not been well established. This study is being conducted through collaboration between the Department of Psychiatry at National Taiwan University Hospital and the National Taiwan Museum.

Approximately 90 autistic adults will be recruited through the outpatient services of National Taiwan University Hospital. After clinical referral and completion of baseline assessments, participants will select one of three museum participation programs, with a target enrollment of approximately 30 participants per group. Because participants choose their preferred program, assignment is nonrandomized.

The three programs are:

  1. Independent Museum Visit: Participants will visit the National Taiwan Museum once at a time of their choosing.
  2. Guided Museum Program: Participants will attend five structured group sessions, with approximately 10-15 participants per group. Each session will last approximately 90 minutes and will include a museum-guided introduction, a question-and-answer period, independent exploration of selected exhibits, and a facilitated group discussion.
  3. Museum Visit With a Friend: Participants will invite a friend or companion to visit the museum with them.

The guided program will use permanent museum exhibitions as prompts for social interaction, reflection, and discussion. Proposed themes include stereotypes and personal identity, relationships between people and nature, ideals and realities of living environments, human evolution and the future, and personal attitudes toward money and financial planning. During the discussion period, participants will share observations or photographs from the exhibits, listen to other participants, provide feedback, and express their own perspectives.

Quantitative assessments will be administered before participation and, for selected measures, after completion of the assigned museum program. Baseline assessments will characterize autism-related traits, social responsiveness, sensory processing, sensory sensitivity, attitudes toward social touch, emotional functioning, loneliness, anxiety, depression, and social interaction anxiety. Post-program assessments will focus on changes in emotional functioning, loneliness, anxiety, depression, and social interaction anxiety, as well as satisfaction with the museum experience.

Participants who complete their selected program may also be invited to take part in a focus group lasting approximately 30-60 minutes. The discussion will explore perceived benefits, difficulties, satisfaction, and recommendations for improving the program. Focus groups will be audio- and video-recorded and transcribed for qualitative analysis.

Quantitative analyses will examine within-participant changes in emotional intelligence, loneliness, anxiety, depression, and social interaction anxiety. Differences among the three participation programs will also be evaluated, including differences in activity satisfaction and changes from baseline. Exploratory analyses will examine whether baseline autism-related, social, and sensory characteristics are associated with program response. Qualitative data will be summarized thematically to identify perceived benefits and areas requiring improvement.

All research records will be identified by study code rather than participant name. Paper records will be stored in locked cabinets, and electronic files, including audio and video recordings, will be stored on password-protected computers. Study data will be retained for 20 years and then destroyed according to institutional procedures.

Being tested
Independent museum visit, Guided museum visits and group discussions, Museum visit with a friend
Keywords
Autism spectrum disorder, ASD, autism, psychosocial intervention, social participation, community-based intervention, cultural participation, autistic adults, social prescribing, museum-based intervention
Medical subject headings
Autism Spectrum Disorder, Autistic Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Independent museum visitBehavioural

    Visit the museum independently on one occasion

  • Guided museum visits and group discussionsBehavioural

    Participants will attend five structured museum sessions. Each group will include approximately 10 to 15 participants. Every session will consist of a guided museum visit followed by a facilitated group discussion.

  • Museum visit with a friendBehavioural

    Participants will invite a friend or companion of their choice to visit the museum with them.

Study groups in NCT07768332
Study groupRoleWhat they receive
Independent museum visitExperimentalWill visit the museum independently on one occasion
Receives: Behavioral: Independent museum visit
Guided museum visits and group discussionsExperimentalWill attend five structured museum sessions with a group of approximately 10 to 15 participants. Every session will consist of a guided museum visit followed by a facilitated group discussion.
Receives: Behavioral: Guided museum visits and group discussions
Museum visit with a friendExperimentalWill invite a friend or companion of their choice to visit the museum with them
Receives: Behavioral: Museum visit with a friend

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Activity satisfaction

    Participants will also complete an activity evaluation based on the University College London Museum Wellbeing Questionnaire.

    The questionnaire contains 12 items rated on a five-point scale from "never" to "always." It assesses whether participants:

    Felt happy. Became absorbed in the activity. Felt comfortable and relaxed. Felt safe and secure. Enjoyed the company of others. Enjoyed talking with other people. Found the activity new and interesting. Enjoyed taking part. Found the activity arrangement engaging. Considered the activity entertaining. Felt confident while participating. Experienced a sense of physical and emotional well-being after the activity.

    Higher scores suggest greater satisfaction.

    Measured: Change from baseline to after the intervention

Secondary outcomes (5)
  1. Loneliness

    Measured using the UCLA Loneliness Scale, a 20-item measure of loneliness and perceived social isolation. Participants indicate how often they experience feelings described in each item. Higher scores indicate more loneliness.

    Measured: Change from baseline to after the intervention

  2. Emotional intelligence

    The Schutte Emotional Intelligence Scale is a 33-item measure of emotional abilities. It assesses areas such as expressing emotions, understanding one's own emotions, understanding the emotions of others, and using emotions to support problem-solving. Higher scores suggest higher emotional intelligence and functioning.

    Measured: Change from baseline to after the intervention

  3. Social interaction anxiety

    The Social Interaction Anxiety Scale is a self-report measure of anxiety experienced during interactions with other people. Participants rate how closely each item reflects their usual experiences. Higher scores indicate greater social interaction anxiety.

    Measured: Change from baseline to after the intervention

  4. Depression

    The Beck Depression Inventory is a 21-item questionnaire used to assess the severity of depressive symptoms. Higher scores indicate more severe depressive symptoms.

    Measured: Change from baseline to after the intervention

  5. Anxiety

    Measured using the Beck Anxiety Inventory, a 21-item questionnaire that assesses the severity of anxiety symptoms during the previous month. It covers physical symptoms, nervous-system responses, panic-related symptoms, and subjective feelings of anxiety. Higher scores indicate more severe anxiety symptoms.

    Measured: Change from baseline to after the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Aug 2026
  2. Study start1 May 2024
  3. Primary completionDec 2027 (estimated)
  4. Study completionDec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07768332
Sponsor's protocol ID
202404073RINA
Status last verified
Jul 2026
First submitted
29 Jul 2026
Last updated
17 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • World Health Organization. (2022). A toolkit on how to implement social prescribing

  • Salovey, P., & Mayer, J. D. (1990). Emotional intelligence. Imagination, Cognition and Personality, 9, 185-211.

  • Saklofske, D. H., Austin, E. J., & Minski, P. S. (2003). Factor structure and validity of a trait emotional intelligence measure. Personality and Individual Differences, 34, 1091-1100.

  • Petrides, K. V., & Furnham, A. (2000). On the dimensional structure of emotional intelligence. Personality and Individual Differences, 29, 313-320.

  • Zheng YP, Wei LA, Goa LG, Zhang GC, Wong CG. Applicability of the Chinese Beck Depression Inventory. Compr Psychiatry. 1988 Sep-Oct;29(5):484-9. doi: 10.1016/0010-440x(88)90063-6.

    PubMed 3180758
  • Yadav UN, Paudel G, Ghimire S, Khatiwada B, Gurung A, Parsekar SS, Mistry SK. A rapid review of opportunities and challenges in the implementation of social prescription interventions for addressing the unmet needs of individuals living with long-term chronic conditions. BMC Public Health. 2024 Jan 27;24(1):306. doi: 10.1186/s12889-024-17736-2.

    PubMed 38279079
  • Chrostek E, Teixeira L. Within host selection for faster replicating bacterial symbionts. PLoS One. 2018 Jan 18;13(1):e0191530. doi: 10.1371/journal.pone.0191530. eCollection 2018.

    PubMed 29346449
  • Wilhelm FH, Kochar AS, Roth WT, Gross JJ. Social anxiety and response to touch: incongruence between self-evaluative and physiological reactions. Biol Psychol. 2001 Dec;58(3):181-202. doi: 10.1016/s0301-0511(01)00113-2.

    PubMed 11698114
  • Wildman JM, Moffatt S, Steer M, Laing K, Penn L, O'Brien N. Service-users' perspectives of link worker social prescribing: a qualitative follow-up study. BMC Public Health. 2019 Jan 22;19(1):98. doi: 10.1186/s12889-018-6349-x.

    PubMed 30670001
  • Simpson S, Furlong M, Giebel C. Exploring the enablers and barriers to social prescribing for people living with long-term neurological conditions: a focus group investigation. BMC Health Serv Res. 2021 Nov 13;21(1):1230. doi: 10.1186/s12913-021-07213-6.

    PubMed 34774034
  • Mulligan K, Bhatti S, Rayner J, Hsiung S. Social Prescribing: Creating Pathways Towards Better Health and Wellness. J Am Geriatr Soc. 2020 Feb;68(2):426-428. doi: 10.1111/jgs.16249. Epub 2019 Dec 16. No abstract available.

    PubMed 31840796
  • Moffatt S, Steer M, Lawson S, Penn L, O'Brien N. Link Worker social prescribing to improve health and well-being for people with long-term conditions: qualitative study of service user perceptions. BMJ Open. 2017 Jul 16;7(7):e015203. doi: 10.1136/bmjopen-2016-015203.

    PubMed 28713072
  • Mistry SK, Harris E, Li X, Harris MF. Feasibility and acceptability of involving bilingual community navigators to improve access to health and social care services in general practice setting of Australia. BMC Health Serv Res. 2023 May 11;23(1):476. doi: 10.1186/s12913-023-09514-4.

    PubMed 37170092
  • Luo N, Fones CS, Thumboo J, Li SC. Factors influencing health-related quality of life of Asians with anxiety disorders in Singapore. Qual Life Res. 2004 Mar;13(2):557-65. doi: 10.1023/B:QURE.0000018484.89711.e2.

    PubMed 15085928
  • Kim YS, Leventhal BL, Koh YJ, Fombonne E, Laska E, Lim EC, Cheon KA, Kim SJ, Kim YK, Lee H, Song DH, Grinker RR. Prevalence of autism spectrum disorders in a total population sample. Am J Psychiatry. 2011 Sep;168(9):904-12. doi: 10.1176/appi.ajp.2011.10101532. Epub 2011 May 9.

    PubMed 21558103

Questions about this trial

What is this clinical trial studying?

A study testing Independent museum visit, Guided museum visits and group discussions and Museum visit with a friend in people with Autism Spectrum Disorder (ASD and Autism, run by National Taiwan University Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 17 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Yi-Ling Chien, MD, PhD (+866+223123456 ext. 266013, ntuh.peers@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Activity satisfaction (time frame: Change from baseline to after the intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07768332, which also lists 30 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in